Last Updated : December 21, 2004
Details
FilesGeneric Name:
Memantine hydrochloride
Project Status:
Complete
Therapeutic Area:
Dementia (Alzheimer type), moderate to severe
Manufacturer:
Lundbeck Canada Inc.
Brand Name:
Ebixa
Project Line:
Reimbursement Review
Project Number:
SR0025-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Dementia (Alzheimer type), moderate to severe
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list
Files
Last Updated : December 21, 2004